Approval of XTANDI in Europe Should be Swift; Aegis Maintains Medivation (MDVN)
Tweet Send to a Friend
Aegis Capital is still bullish on Medivation, Inc. (Nasdaq: MDVN) following news last week that the company and Astellas submitted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE